Description: Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Home Page: www.oppharma.com
No. 368, Fu Hsing South Road
Taipei,
106
Taiwan
Phone:
886 2 2325 7621
Officers
| Name | Title |
|---|---|
| Mr. Chun-Tong Huang | General Manager |
| Yi Xin Zhang | Chief Financial Officer |
| Zhi Cheng Lu | Chief Operating Officer |
| Mr. Calvin Tsai | GM & Director |
Exchange: TWO
Country: TW : Taiwan
Currency: New Taiwan Dollar (NT$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 70.3774 |
| Price-to-Book MRQ: | 5.0246 |
| Price-to-Sales TTM: | 7.8066 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |